Cargando…
Effects of a Guideline-Informed Clinical Decision Support System Intervention to Improve Colony-Stimulating Factor Prescribing: A Cluster Randomized Clinical Trial
IMPORTANCE: Colony-stimulating factors are prescribed to patients undergoing chemotherapy to reduce the risk of febrile neutropenia. Research suggests that 55% to 95% of colony-stimulating factor prescribing is inconsistent with national guidelines. OBJECTIVE: To examine whether a guideline-based st...
Autores principales: | Ramsey, Scott D., Bansal, Aasthaa, Sullivan, Sean D., Lyman, Gary H., Barlow, William E., Arnold, Kathryn B., Watabayashi, Kate, Bell-Brown, Ari, Kreizenbeck, Karma, Le-Lindqwister, Nguyet A., Dul, Carrie L., Brown-Glaberman, Ursa A., Behrens, Robert J., Vogel, Victor, Alluri, Nitya, Hershman, Dawn L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Medical Association
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9593234/ https://www.ncbi.nlm.nih.gov/pubmed/36279134 http://dx.doi.org/10.1001/jamanetworkopen.2022.38191 |
Ejemplares similares
-
Successes and challenges of implementing a cancer care delivery intervention in community oncology practices: lessons learned from SWOG S1415CD
por: Watabayashi, Kate K., et al.
Publicado: (2022) -
An evaluation of stakeholder engagement in comparative effectiveness research: lessons learned from SWOG S1415CD
por: Bell-Brown, Ari, et al.
Publicado: (2022) -
Effective stakeholder engagement: design and implementation of a clinical trial (SWOG S1415CD) to improve cancer care
por: Barger, Sarah, et al.
Publicado: (2019) -
Role of denosumab in the management of skeletal complications in patients with bone metastases from solid tumors
por: Brown-Glaberman, Ursa, et al.
Publicado: (2012) -
Impact of denosumab on bone mass in cancer patients
por: Brown-Glaberman, Ursa, et al.
Publicado: (2013)